Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (1403)	4/1/2003 10:42:23 PM
From: tuck	Read Replies (1) \| Respond to of 1784

Several Trickle companies whined last quarter about the delayed NIH budget. This was actually somewhat justified, but the the budget has been passed. The bad news, the increases are over; '04 will be almost flat. But for now, trickle company customers relying on NIH funds should start getting them, and it should start flowing through to the trickle companies. Those involved in biodefense are getting a healthy chunk, natch: biotechjournal.com Cheers, Tuck